Searched for
AJINOMOTO INDIA MARKETING
Relief for Nestle as NCDRC dismisses govt's 2015 plea against sale of Maggi noodlesThe National Consumer Dispute Redressal Commission dismissed the Central government's plea against Nestle India for alleged unfair trade pr...- Nikkei edges higher on tech rally but Nintendo, sauce makers cap gainsThe Nikkei 225 ended the day 0.16% higher after swinging between small gains and losses throughout the session in holiday-thinned trading. ...
- MSG myths and distractions: So why is McDonald’s trying to break the MSG taboo?The flavour enhancer has been held responsible for causing migraines, racing heartbeats and rather unfairly, called ‘Chinese restaurants’ s...
- Japanese food giant Ajinomoto to create awarness about safe consumption of MSG product in IndiaThe Indian subsidiary of Japan-headquartered company currently imports aji-no-moto from its Thailand factory which mainly serves to the Sou...
- Strong fundamentals, reasonable valuations make analysts bullish on Granules IndiaMore analysts are getting attracted to this counter because the recent correction has brought down its valuations to reasonably levels.
- Nestle falls as government sues company over Maggi row; seeks Rs 640 crore in damagesNestle India fell 4.70 per cent in trade on Wednesday after the government claimed damages worth Rs 640 crore from the company.
- Maggi ban: BJP-led government sues Nestle for Rs 640 croreThis is the first class action suit filed with the National Consumer Disputes Redressal Commission (NCDRC), consumer affairs ministry offic...
- Granules India to raise Rs 250 cr via QIP: VVS Murthy"On 28th January board meeting directors have approved fundraising plans for Rs 250 crore. We are calling for shareholders meeting on 27th ...
- Top five lesser known companies poised to ride the big bull run on Dalal StreetMost of the high beta stocks have more than doubled in the past one year, but analysts feel that there is more upside left in the benchmark...
- Granules India eyes Rs 1,000 cr turnover this fiscalMid-sized pharmaceutical company Granules India is eying to achieve Rs 1,000 crore of revenue during the current financial year 2013-14.
Load More
